Abstract 2673: Inhibition of fatty-acid oxidation as a therapy for MYC-overexpressing triple-negative breast cancer
Roman Camarda(University of California, San Francisco), Andrei Goga(University of California, San Francisco), Henok Eyob(University of California, San Francisco), Daniel K. Nomura(Berkeley College), Rebecca A. Kohnz(Merck & Co., Inc., Rahway, NJ, USA (United States)), Céline I. Mahieu(University of California, San Francisco), Sanjeev Balakrishnan(University of California, San Francisco), Alicia Y. Zhou(Whitehead Institute for Biomedical Research), Shingo Kajimura(Hadassah Medical Center), Brittany Anderton(Gladstone Institutes), Gregor Krings(Cleveland Clinic), Aaron D. Tward(Eli Lilly (United States))
Cited by 0
Related Papers
Oncogenic Signaling Pathways in The Cancer Genome Atlas
|Cell|2018|3.4k
Analytical and clinical validation of a microbial cell-free DNA sequencing test for infectious disease
|Nature Microbiology|2019|1k